Chronic use of proton pump inhibitors: Is the risk of osteoporosis and fractures real?

被引：1
|
作者：
Marti-Cabrera, Miguel [1 ,2 ]
Marti-Masanet, Miguel [1 ]
Esplugues, Juan V. [1 ,2 ,3 ]
机构：
[1] Univ Valencia, Dept Farmacol, Fac Med & Odontol, E-46003 Valencia, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Valencia, Spain
[3] Hosp Univ Dr Peset Aleixandre, Valencia, Spain
来源：
GASTROENTEROLOGIA Y HEPATOLOGIA | 2011年 / 34卷 / 04期
关键词：
PPI; calcium; toxicity; fractures; osteoporosis; inhibition of acid secretion; GASTRIC-ACID SECRETION; BONE-MINERAL DENSITY; L-LACTIC ACID; HIP FRACTURE; CALCIUM-ABSORPTION; RESORPTION; PHOSPHATE; OMEPRAZOLE; SAFETY; WOMEN;
D O I：
10.1016/j.gastrohep.2011.01.002
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Proton pump inhibitors (PPI) are one of the most widely used groups of drugs and their potential toxicity is periodically reviewed, emphasizing aspects originally considered secondary. The present review analyzes the physiological and pharmacological bases and the scarce clinical evidence for a potential association between the continued administration of PPI and the development of osteoporosis and bone fractures. Both disorders are clearly related to calcium homeostasis and are highly important in elderly patients due to their poor general prognosis and disabling consequences. (C) 2010 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码：271 / 277
页数：7
相关论文
共 50 条
  • [41] Use of Proton Pump Inhibitors and the Risk of Hospitalization for Infectious Gastroenteritis
    Chen, Yingxi
    Liu, Bette
    Glass, Kathryn
    Du, Wei
    Banks, Emily
    Kirk, Martyn
    PLOS ONE, 2016, 11 (12):
  • [42] Proton pump inhibitors use and fracture risk in young adults
    Lai, Shih-Wei
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (07)
  • [43] Proton-pump inhibitors and risk of fractures: an update meta-analysis
    Zhou, B.
    Huang, Y.
    Li, H.
    Sun, W.
    Liu, J.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (01) : 339 - 347
  • [44] Proton-pump inhibitors and risk of fractures: an update meta-analysis
    B. Zhou
    Y. Huang
    H. Li
    W. Sun
    J. Liu
    Osteoporosis International, 2016, 27 : 339 - 347
  • [45] Do opioids, sedatives and proton-pump inhibitors increase the risk of fractures?
    Porsdottir, Guolaug
    Benedikz, Elisabet
    Porgeirsdottir, Sigriour A.
    Johannsson, Magnus
    LAEKNABLADID, 2017, 103 (05): : 231 - 235
  • [46] What is the REAL long-term risk of proton pump inhibitors?
    Ribiere, Sophie
    Guillaumot, Marie-Anne
    Barre, Amelie
    Abou Ali, Einas
    Barret, Maximilien
    Chaussade, Stanislas
    Coriat, Romain
    PRESSE MEDICALE, 2019, 48 (05): : 503 - 510
  • [47] Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis
    da Maia, Thuila Ferreira
    de Camargo, Bruna Gafo
    Pereira, Meire Ellen
    de Oliveira, Claudia Sirlene
    Guiloski, Izonete Cristina
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (20)
  • [48] IMPACT OF PROTON PUMP INHIBITORS ON FEMORAL NECK OSTEOPOROSIS
    Hankollari, J.
    Duraj, V.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S332 - S332
  • [49] Proton Pump Inhibitors and Osteoporosis: Is Collagen a Direct Target?
    Ghebre, Yohannes T.
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [50] Bariatric surgery, proton pump inhibitors, and possibility of osteoporosis
    Deitel, Mervyn
    SURGERY FOR OBESITY AND RELATED DISEASES, 2010, 6 (04) : 461 - 462
12345